Apimeds Pharmaceuticals US Inc banner
A

Apimeds Pharmaceuticals US Inc
AMEX:APUS

Watchlist Manager
Apimeds Pharmaceuticals US Inc
AMEX:APUS
Watchlist
Price: 1.91 USD 17.18% Market Closed
Market Cap: $24m

Cash Flow Statement

Cash Flow Statement
Apimeds Pharmaceuticals US Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2022 Dec-2023 Dec-2024
Operating Cash Flow
Net Income
(1)
(1)
(1)
Stock-Based Compensation
0
0
0
Other Non-Cash Items
0
0
0
Change in Working Capital
(0)
0
1
Cash from Operating Activities
(0)
N/A
(1)
-40%
(1)
-17%
Investing Cash Flow
Other Items
0
0
0
Cash from Investing Activities
0
N/A
0
N/A
0
N/A
Financing Cash Flow
Net Issuance of Common Stock
0
1
0
Net Issuance of Debt
0
0
0
Other
0
(0)
0
Cash from Financing Activities
0
N/A
1
+265%
0
-68%
Change in Cash
Net Change in Cash
(0)
N/A
0
N/A
(0)
N/A
Free Cash Flow
Free Cash Flow
(0)
N/A
(1)
-40%
(1)
-17%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett